Dr. Roz MD, MEDSPA at Total Health and Wellness - Dr. Rosalind Mascall GYN
4000 Miamisburg Centerville Road · Miamisburg, OH 45342
4.5(362 Google reviews · 26 in past year)
Accepts insurance
Listing updated Oct 2, 2026
WoodStream Wellness
WoodStream Wellness · 9049 North Springboro Pike · Miamisburg, OH 45342
3.7· 88 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
WoodStream Wellness is primarily a mental health practice with four locations in Dayton and Cincinnati, Ohio, according to its website, and its Miamisburg listing also includes weight-loss care; the site offers a separate path for weight loss patients. It says it treats patients starting at age 5 and describes its clinicians as board-certified specialists. On Google the Miamisburg location holds a 3.7-star rating across 88 reviews dating back to 2024, with 22 in the past year; reviewers most often mention feeling cared for, scheduling and the providers' knowledge.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 3.7
Google rating · 88 reviews
22
reviews in the past year (avg ★ 3.0)
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-16. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★3.7 across 88 Google reviews. Of the 48 reviews we analyzed, 27 (56%) are positive (4–5★) and 20 (42%) are negative (1–2★).
What patients like
- Feeling listened to12 reviews
- Friendly, helpful staff5 reviews
- Knowledgeable, professional providers5 reviews
- Easy scheduling and communication3 reviews
Common complaints
- Scheduling or communication problems7 of 20 negative
- Staff or front-desk issues3 of 20 negative
- Felt rushed or unheard2 of 20 negative
5★
27
4★
0
3★
1
2★
4
1★
16
Most recent Google reviews
Diane M.★★★★★2026-09-16Good luck getting someone to call back for an appointment. After 4 days I found another clinic that actually answered their calls.
Shannon P.★★★★★2026-09-08Christina Alcorn is a wonderful therapist. I look forward to talking to her. She has helped me tremendously. Thank you so much.
nick m.★★★★★2026-08-27Woodstream has been great...Both NP's I've worked with have been nice and listened to my concerns. I haven't felt this good in awhile. Would highly recommend!
Sunshine B.★★★★★2026-08-1810/10 Ashleigh Heitzman has listened to me and I feel like we’ve partnered to find the best treatment for me. (Which seems to be do rare in healthcare these days.) My experience with the office staff is pleasant also. I really don’t have to contact them much because the portal can assist me with most needs and my provider always schedules my next appointment before we end our current one. So grateful that I found woodstream wellness.
Destiny R.★★★★★2026-08-16Great children therapist, whom advocate for the child.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Miamisburg
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs